Recoding Life, Improving Health

Flash Therapeutics

COVID-19 RELATED MEASURES

Flash Therapeutics resumed its production and analytical activities on Monday March 23rd in order to ensure the follow-up of our clinical research work, as well as that of our partners and customers. As soon as the technical activities are completed, the concerned teams will return home and ensure traceability and follow-up remotely. All managers are committed to organizing the daily routine and logistics around on-site activities to ensure the safety of our employees present. Since the beginning of this health crisis, and in compliance with government regulations, all Flash Therapeutics’ employees who are able to continue their work remotely have been able to do so from home. All Flash Therapeutics’ employees are now connected from home. Should government measures change then we will keep you informed of our activity.

Who we are?
Flash Therapeutics

Therapeutics

Using the LentiFlash® technology, Flash Therapeutics can recover a wide range of therapeutic fields

Technology

Non-integrating lentiviral particles called LentiFlash® for transient RNA delivery

flash therapeutics techno1

The revolutionary lentiflash® technology

symbole
Scalable and reproducible production process

Vectalys’ Lentiviral manufacturing platform

flash therapeutics techno2

Pipeline

Discover our own internal product candidates and collaborative programmes

Know more

World-leading partners

Become a partner

We look forward to negotiate partnerships and licensingagreements with pharmaceutical or biotechnological companiesfor the utilization, further development and globalcommercialization of the proprietary LentiFlash® delivery system.

Join us
Flash Therapeutics

News & events

All News & Events